Application of nanoparticles to reverse multi-drug resistance in cancer

被引：7
|
作者：
Yang, Jie [1 ]
Zhang, Haijun [1 ]
Chen, Baoan [1 ]
机构：
[1] Southeast Univ, Sch Med, Zhongda Hosp, Dept Hematol & Oncol, Nanjing 210009, Jiangsu, Peoples R China
来源：
NANOTECHNOLOGY REVIEWS | 2016年 / 5卷 / 05期
关键词：
cancer; multi-drug resistance (MDR); nanoparticles (NPs); MESOPOROUS SILICA NANOPARTICLES; OVERCOME DRUG-RESISTANCE; VINCRISTINE SULFATE DELIVERY; SOLID LIPID NANOPARTICLES; BREAST-CANCER; CO-DELIVERY; MULTIFUNCTIONAL NANOPARTICLES; IN-VITRO; MAGNETIC NANOPARTICLES; HYALURONIC-ACID;
D O I：
10.1515/ntrev-2016-0023
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Multi-drug resistance (MDR) poses a large obstacle to various human malignancies. For a long period, combination of multiple therapeutic agents has been the conventional method used to reverse MDR in cancer. However, it is still not an effective method as rather than cancer its serious side effects causes patient's death. Nanoparticles (NPs) are emerging as a class of therapeutics for cancer, including overcoming MDR. In the present review, we focus on the application of NPs to reverse MDR in cancer. Several kinds of NPs developed for the reversal of MDR are summarized. In addition, investigations in vitro and in vivo are also shown to highlight the advancement in the application of NPs to reverse MDR.
引用
收藏
页码：489 / 496
页数：8
相关论文
共 50 条
  • [41] Co-delivery of multiple drug resistance inhibitors by polymer/inorganic hybrid nanoparticles to effectively reverse cancer drug resistance
    Wu, Cong
    Gong, Meng-Qing
    Liu, Bo-Ya
    Zhuo, Ren-Xi
    Cheng, Si-Xue
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2017, 149 : 250 - 259
  • [42] A Three-drug co-Delivery System Based on Reduction-sensitive Polymeric Prodrug to Effectively Reverse Multi-drug Resistance
    Xu Jiaqi
    Yi Xiaoqing
    Zhao Dan
    Yuan Gongdao
    Zhuo Renxi
    Li Feng
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2017, 33 (03) : 484 - 491
  • [43] A three-drug co-delivery system based on reduction-sensitive polymeric prodrug to effectively reverse multi-drug resistance
    Jiaqi Xu
    Xiaoqing Yi
    Dan Zhao
    Gongdao Yuan
    Renxi Zhuo
    Feng Li
    Chemical Research in Chinese Universities, 2017, 33 : 484 - 491
  • [44] Glycan-based scaffolds and nanoparticles as drug delivery system in cancer therapy
    Qin, Henan
    Teng, Yibin
    Dai, Rui
    Wang, Aman
    Liu, Jiwei
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [45] iRGD-targeted hybrid nanoparticles reverses multi-drug resistant to effectively combat liver cancer
    Zhao, Jie
    Wen, Bin
    Tan, Zhengbing
    Li, Xinyan
    Zhang, Xuesong
    JOURNAL OF DRUG TARGETING, 2020, 28 (10) : 1063 - 1070
  • [46] Mitochondrial transfer from Adipose stem cells to breast cancer cells drives multi-drug resistance
    Del Vecchio, Vitale
    Rehman, Ayesha
    Panda, Sameer Kumar
    Torsiello, Martina
    Marigliano, Martina
    Nicoletti, Maria Maddalena
    Ferraro, Giuseppe Andrea
    De Falco, Vincenzo
    Lappano, Rosamaria
    Lieto, Eva
    Pagliuca, Francesca
    Caputo, Carlo
    La Noce, Marcella
    Papaccio, Gianpaolo
    Tirino, Virginia
    Robinson, Nirmal
    Desiderio, Vincenzo
    Papaccio, Federica
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [47] Lathyrane diterpenes from Euphorbia lathyris and the potential mechanism to reverse the multi-drug resistance in HepG2/ADR cells
    Yang, Tao
    Wang, Siyi
    Li, Hongmei
    Zhao, Qun
    Yan, Shili
    Dong, Miao
    Liu, Dan
    Chen, Xuanqin
    Li, Rongtao
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 121
  • [48] The therapeutic potential of targeting ABC transporters to combat multi-drug resistance
    Bugde, Piyush
    Biswas, Riya
    Merien, Fabrice
    Lu, Jun
    Liu, Dong-Xu
    Chen, Mingwei
    Zhou, Shufeng
    Li, Yan
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (05) : 511 - 530
  • [49] Multi-Drug Resistance and Breast Cancer Progression via Toll-Like Receptors (TLRs) Signaling
    Pallathadka, Harikumar
    Khaleel, Abdulrahman Qais
    Zwamel, Ahmed Hussein
    Malathi, H.
    Sharma, Snehlata
    Rizaev, Jasur Alimdjanovich
    Mustafa, Yasser Fakri
    Pramanik, Atreyi
    Alubiady, Mahmood Hasen Shuhata
    Jawad, Mohammed Abed
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, 82 (04) : 3015 - 3030
  • [50] A Multi-Drug Pharmacokinectic Optimal Control Approach in Cancer Chemotherapy
    M. P. Rajan
    C. K. Nanditha
    Journal of Optimization Theory and Applications, 2022, 195 : 314 - 333
12345